EXPONENT INC. - 10-Q Filing Summary
Business Context and Reporting Period
Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended July 4, 2003
Business Overview: An engineering and scientific consulting firm providing solutions to complex problems in environmental, health, litigation, and technology development sectors. The company operates on a 52-53 week fiscal year.
Key Financial Metrics
| Metric (in thousands) | Q2 2003 | Q2 2002 | 6 Months 2003 | 6 Months 2002 |
|---|---|---|---|---|
| Total Revenues | $34,922 | $31,632 | $69,737 | $62,244 |
| Operating Income | $4,508 | $3,618 | $8,597 | $7,520 |
| Net Income | $2,674 | $2,123 | $5,143 | $4,042 |
| Diluted EPS | $0.34 | $0.28 | $0.65 | $0.54 |
| Cash & Equivalents | $26,050 | $22,480 (Jan 3, 2003) | $26,050 | $7,815 (Jan 4, 2002) |
| Operating Cash Flow (6mo) | $3,543 (vs $4,659 prior year) | |||
| Long-Term Debt | $197 (Capital leases; Revolving credit line unused) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 10% in Q2 and 12% for the six months ended July 4, 2003, compared to the prior year. Growth was driven by increased billable hours, higher billing rates, and the integration of the Novigen Sciences acquisition.
- Profitability: Net income rose 26% in Q2 and 27% for the six-month period. Operating margins improved slightly as compensation and other operating expenses decreased as a percentage of revenue.
- Expense Drivers: Compensation expenses increased 9% (Q2) and 10% (6mo) due to salary increases, headcount growth, and the Novigen acquisition. Other operating expenses rose primarily due to higher occupancy costs from new leases in Philadelphia and New York.
- Cash Flow: Net cash provided by operating activities decreased to $3.5 million for the six months ended July 4, 2003, compared to $4.7 million in the prior year, largely due to a $2.4 million increase in accounts receivable.
Outlook, Risks, and Management Commentary
- Segment Performance: The "Other scientific and engineering" segment contributed the majority of revenue growth ($2.4M in Q2), while the "Environmental and health" segment grew due to the Novigen acquisition.
- Liquidity: The company maintains strong liquidity with $26.1 million in cash and a $24.5 million revolving credit facility with zero outstanding balance. Management believes existing resources are sufficient for the next 12 months.
- Subsequent Event: Between July 5 and August 8, 2003, the company repurchased 120,000 shares of common stock for $2 million. $5.1 million remains authorized under the repurchase program.
- Risks:
- Absence of Backlog: Backlog is small and not a reliable indicator of future revenue due to the nature of client-requested services.
- Customer Concentration: Significant revenue is derived from the transportation industry and government sector; loss of a large client could be material.
- Key Personnel: Success depends on attracting and retaining highly qualified technical staff in a competitive market.
- Economic Sensitivity: Demand is cyclical and subject to general economic conditions.
Investor Verification Checklist
- Accounts Receivable Aging: Verify the $40.2 million receivable balance and the $1.5 million allowance for doubtful accounts, noting the increase in days sales outstanding to 99 days.
- Novigen Integration: Assess the long-term contribution of the Novigen Sciences acquisition to the Environmental and Health segment margins.
- Stock-Based Compensation: Review pro-forma net income ($2.18M for Q2) if the fair value method were used, which is significantly lower than reported net income ($2.67M).
- Fixed-Price Contract Risks: Evaluate the company's exposure to cost overruns on fixed-price contracts, as losses are recognized immediately when evident.
- Recurring Revenue Stability: Confirm the stability of the transportation and government client base given the stated concentration risk.